RISK STRATIFICATION AND INTENSIVE THERAPY IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN CLINICAL PRACTICE

Аннотация:

This study evaluates the application of risk stratification and intensive therapy principles in the clinical management of patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). A retrospective analysis was performed on clinical data from 76 hospitalized patients. The findings revealed that formal risk stratification at admission was not documented in routine practice. Reassessment using the TIMI risk score demonstrated that the majority of patients belonged to low- and intermediate-risk categories. Pharmacological management, including anticoagulant, antiplatelet, β-blocker, and statin therapy, was generally consistent with contemporary clinical guidelines, although certain deviations and unjustified omissions were identified. The results underscore the critical importance of implementing validated risk assessment tools, such as GRACE and TIMI scores, to optimize therapeutic strategies, improve prognostic accuracy, and enhance clinical outcomes in patients with NSTE-ACS.